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Abstract 
  We  report  a  50-year-old  woman  with  primary  Sjögren’s  syndrome  (SjS)  who  
initially  showed  forgetfulness,  and  later  developed  disturbance  of  consciousness.   In  
addition  to  aseptic  meningoencephalitis  revealed  by  cerebrospinal  fluid  examination  
and  magnetic  resonance  imaging  (MRI),  the  presence  of  serum  anti-SS-A  and  
anti-SS-B  antibodies  and  inflammatory  findings  in  lip  biopsy  indicated  primary  SjS.  
Fluid  attenuated  inversion  recovery  (FLAIR)  of  MRI  revealed  well  defined  small,  
high  signal  intensity  areas  in  the  cortex  involving  the  the  subcortical  white  
matter.  Corticosteroid  therapy  resulted  in  rapid  and  nearly  complete  resolution  of  
the  cortical  lesions  with  marked  improvement  of  the  clinical  manifestations.  
Memory  disturbance  is  a  rare  initial  manifestation  in  meningoencephalitis  associated  
with  SjS.  Our  patient  with  SjS  showed  inflammatory  cortical  lesions  on  MRI,  
which  were  reversed  by  corticosteroid  therapy.   
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1.  Introduction 
   Central  nervous  system  complications  have  been  reported  in  up  to  25%  of  
patients  with  Sjögren’s  syndrome  (SjS)  [1];  meningitis  is  common  in  SjS  patients  
[2].  There  have  been  previous  reports  of  SjS  patients  showing  meningoencephalitis  
without  characteristic  symptoms  of  xerosis  [6].  As  meningoencephalitis  in  primary  
SjS  is  treatable,  understanding  of  its  clinical  features  is  important  in  the  
differential  diagnosis  of  meningoencephalitis.  There  have  been  no  previous  reports  
of  detailed  magnetic  resonance  imaging  (MRI)  findings  of  such  cases.  Here,  we  
report  a  case  of  primary  SjS  presenting  with  aseptic  meningoencephalitis  showing  
reversible  cortical  lesions  on  MRI.   
 
2.  Case report  
   The  patient  was  a  50-year-old  Japanese  woman.  She  had  no  history  of  
cardiovascular  risk  factors  such  as  hypertension,  diabetes  mellitus,  smoking,  
hyperlipidemia,  heavy  drinking,  or  drug  use.  Her  family  history  was  not  
contributory.  Two  weeks  before  admission  to  our  hospital,  she  complained  of  
forgetfulness,  which  was  followed  by  a  low-grade  fever.  When  she  visited  a  
local  hospital,  clinical  examinations  and  brain  computed  tomography  (CT)  revealed  
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no  abnormalities.  On  the  day  before  admission,  she  developed  psychosis.   
Mononuclear  pleocytosis  (63  cells/mm2)  was  noted  in  the  cerebrospinal  fluid  (CSF).   
Technetium-99m  ethyl  cysteinate  dimer  (99mTc-ECD)  brain  single  photon  emission  
computed  tomography  (SPECT)  perfusion  imaging  for  cerebral  blood  flow  revealed  
regions  of  decreased  uptake  in  the  parietal  lobes.  Brain  MRI,  and  magnetic  
resonance  angiography  (MRA)  were  normal.   
   On  the  day  of  admission  (day  1),  the  patient’s  body  temperature  was  36.7℃.   
She  had  no  xerophthalmia,  xerostomia,  uveitis,  mucocutaneous  lesions,  eruption,  
arthritis  or  Raynaud’s  phenomenon.  Neurological  examinations  revealed  disturbance  of  
consciousness  (Glasgow  coma  scale  =  12;  E4-V2-M6)  with  delirium,  mutism,  
ocular  bobbing,  and  urinary  retention,  but  no  nuchal  stiffness.  During  the  first  
day,  her  consciousness  disturbance  showed  rapid  deterioration  with  a  fever  of  
38℃.  On  day  5,  she  fell  into  a  coma  showing  roving  eye  movement,  
decorticate  posture  of  the  upper  limbs,  positive  Babinski  signs,  and  loss  of  deep  
tendon  reflexes  in  the  lower  limbs.   
   Initial  laboratory  evaluation  included  an  increase  in  erythrocyte  sedimentation  rate  
(ESR)  (33.2  mm  in  1h),  negative  C-reactive  protein  (CRP)  (0.3  mg/dl),  positive  
antinuclear  (101.4  titer),  anti-SS-A  (135.3)  and  anti-SS-B  (28.9)  antibodies,  positive  
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rheumatoid  factor,  and  polyclonal  elevation  of  serum  immunoglobulins.  
Anti-double-stranded  DNA  antibodies,  plasma  complement,  and  thyroid  function  were  
negative  or  normal.  Lumbar  puncture  revealed  mononuclear  pleocytosis  (43  
cells/mm2)  with  mildly  elevated  protein  (56  mg/dl)  and  normal  glucose  levels  (46  
mg/dl).  Further  analysis  of  the  cerebrospinal  fluid  (CSF)  indicated  an  increase  in  
IgG  index  (0.832),  and  normal  or  negative  results  for  the  following  tests:  IL-6,  
gram  stain,  Ziehl-Neelsen  stain,  India  ink  preparation,  and  cultures  for  bacteria,  
tubercle  bacillus  mycobacteria,  and  fungi.  Paired  serologic  tests  for  viruses,  
including  herpes  simplex,  herpes  zoster,  Epstein-Barr,  mumps,  rubella,  and  
cytomegalovirus,  and  cryptococcal  latex  agglutination  test  gave  negative  results.   
   On  day  5,  fluid  attenuated  inversion  recovery  (FLAIR)  and  T2-weighted  MR 
images  demonstrated  abnormal  high  signal  areas  in  the  cortical  and  subcortical  
white  matter,  including  the  right  occipital  cortex  and  left  insular  cortices  with  no  
gadolinium-enhancement  (Fig.  1A).  Electroencephalogram  (EEG)  on  day  6  revealed  
diffusely  abnormal  slow  activities,  especially  in  the  occipital  lobes.  Biopsy  of  the  
minor  salivary  gland  from  the  lip  revealed  a  mildly  atrophic  gland  surrounded  
by  focal  infiltration  of  lymphoplasmacytic  cells  (focus  score  1).  Salivary  gland  
scintigraphy  showed  delayed  uptake  and  reduced  concentration  of  technetium-99m-O4-  
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(99mTcO4-)  indicating  salivary  gland  dysfunction.  Schirmer’s  test  revealed  a  significant  
decrease  in  lachrymal  secretion,  which  indicated  subclinical  xerophthalmia.   
   After  establishment  of  a  diagnosis  of  primary  SjS  with  aseptic  
meningoencephalitis  based  on  the  positive  results  of  serological  tests  and  lip  
biopsy,  the  patient  was  treated  with  pulsed  therapy  with  intravenous  
methylprednisolone  at  1  g/day  for  three  days  four  times,  followed  by  oral  
administration  of  prednisolone  at  60  mg/day  with  gradual  tapering  of  the  dose.  
Corticosteroid  therapy  resulted  in  marked  improvement  of  both  consciousness  and  
CSF  findings.   The  abnormal  MRI  findings  disappeared  on  day  40  (Fig.  1B).  
The  EEG  and  SPECT  findings  were  normalized  within  2  months.  She  was  
discharged  from  our  hospital  on  foot  with  mild  memory  disturbance,  dysarthria,  
and  ataxic  movement  two  months  after  admission.  There  has  been  no  recurrence  
of  meningoencephalitis  or  other  manifestations  of  SjS  during  the  following  four  
years.   
  
3.  Discussion 
   We  described  a  patient  with  primary  SjS  who  initially  developed  subacute  
aseptic  meningoencephalitis.  Although  the  patient  was  free  of  sicca  symptoms,  the  
6 
M.  Hirohata  et  al. 
significant  decrease  in  salivary  and  lachrymal  secretion,  inflammatory  cell  infiltration,  
and  the  presence  of  anti-SS-A  and  anti-SS-B  antibodies  satisfied  the  diagnostic  
criteria  for  definite  SjS  [10].  Subacute  progression  of  memory  disturbance  and  
disturbance  of  consciousness  were  the  initial  symptoms  of  aseptic  
meningoencephalitis  associated  with  primary  SjS  in  this  patient.   
   Among  SjS  patients  with  aseptic  meningoencephalitis  [2,  3,  4,  5,  6],  there  
have  been  a  few  rare  cases  in  which  the  patient  presented  with  
meningoencephalitis  as  the  initial  manifestation  [6];  in  such  cases,  including  our  
patient,  memory  impairment  and  disturbance  of  consciousness  are  common  
neuropsychiatry  symptoms.  The  present  patient  showed  characteristic  brain  MRI  
findings  of  well  defined  multiple  focal  lesions  involving  the  occipital  and  limbic  
cortex,  which  disappeared  after  corticosteroid  therapy.   
   In  SjS  patients  with  neuropsychiatry  manifestations,  focal  brain  lesions  on  MRI  
have  been  reported  to  be  located  predominantly  within  the  periventricular  or  
subcortical  white  matter  [7,  9],  except  in  one  case  in  which  the  lesions  were  
confined  to  the  limbic  cortex  [6].  In  our  patient,  the  remarkable  response  of  the  
cortical  lesions  involving  the  white  matter  to  steroid  therapy  indicated  inflammatory  
pathogenesis  of  the  lesions.  There  have  been  a  few  pathological  studies  of  
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meningoencephalitis  associated  with  SjS  [3,  8].  Necrotizing  vasculitis  involving  
numerous  small  arteries  and  arterioles  was  found  diffusely  in  the  cerebral  cortex  
of  one  case  at  necropsy  [8].  Another  case  showed  microinfarcts  and  focal  
laminar  necrosis,  but  no  evidence  of  active  or  healed  vasculitis  or  parenchymal  
infiltration  of  inflammatory  cells  [3].  Although  no  neuropathological  study  was  
performed  in  our  patient,  the  lack  of  enhancement  by  
gadolinium-ethylene-diamine-tetraacetic  acid  (Gd-EDTA)  on  MRI  suggested  minimal  
injury  of  vascular  endothelial  cells  even  if  small  vessels  were  involved  by  
meningocortical  inflammation.   
   Finally,  we  emphasize  that  evidence  of  SjS  should  be  investigated  in  cases  of  
aseptic  meningoencephalitis  even  when  sicca  symptoms  are  absent,  as  in  our  
patient  who  showed  isolated  occurrence  of  meningoencephalitis  without  other  
manifestations  of  SjS  for,  at  least,  four  years.  Furthermore,  MRI  findings  are  
useful  to  demonstrate  the  inflammatory  cortical  lesions  in  SjS,  which  are  
reversible  in  response  to  corticosteroid  therapy.   
 
8 
M.  Hirohata  et  al. 
References 
[1] Alexander  EL,  Provost  TT,  Stevens  MB,  Alexander  GE.  Neurological  
complication  of  primary  Sjögren's  syndrome.  Medicine  1982;  61:  247-57.   
[2] Alexander  EL,  Alexander  GE.  Aseptic  meningoencephalitis  in  primary  Sjögren’s  
syndrome.  Neurology  1983;  33:  593-98.    
[3] Gerraty  RP,  McKelvie  PA,  Byrne E.  Aseptic  meningoencephalitis  in  primary  
Sjögren's  syndrome.  Response  to  plasmapheresis  and  absence  of  CNS  vasculitis  
at  autopsy.  Acta  Neurol  Scand  1993;  88:  309-11.   
[4] Giordano  MJ,  Commins  D,  Silbergeld  DL.  Sjögren's  cerebritis  complicated  by  
subarachnoid  hemorrhage  and  bilateral  superior  cerebellar  artery  occlusion:  case  
report.  Surg  Neurol  1995;  43:  48-51.   
[5] Miyagawa  S,  Iida  T,  Fukumoto  T,  Matsunaga  T,  Yoshioka  A,  Shirai  T.  
Anti-Ro/SSA-associated  annular  erythema  in  childhood.  Br  J  Dermatol  1995;  
133:  779-82.   
[6] Ide  T,  Iizuka  T,  Tsukahara  S,  Suzuki  N,  Sakai  F.  Two  cases  of  acute  
limbic  encephalitis  associated  with  Sjögren’s  syndrome.  Shinkeinaika  (Neurol  
Med)  2003;  59:  121-27  (in Japanese).   
[7] Alexander  EL,  Beall  SS,  Gordon  B,  Selnes  OA,  Yannakakis  GD,  Patronas  N,  
9 
M.  Hirohata  et  al. 
Provost  TT,  McFarland  HF.  Magnetic  resonance  imaging  of  cerebral  lesions  in  
patients  with  the  Sjögren  syndrome.  Ann  Intern  Med  1988;  108:  815-23.   
[8] Kaltreider  HB,  Talal  N.  The  neuropathy  of  Sjögren's  syndrome.  Trigeminal  
nerve  involvement.  Ann  Intern  Med  1969;  70:  751-62.   
[9] Kawashima  N,  Shindo  R,  Kohno  M.  Primary  Sjögren's  syndrome  with  
subcortical  dementia.  Intern  Med  1993;  32:  561-64.   
[10]  Vitali  C,  Bombardieri  S,  Jonsson  R,  Moutsopoulos  HM,  Alexander  EL,  
Carsons  SE,  Daniels  TE,  Fox  PC,  Fox  RI,  Kassan   SS,  Pillemer  SR,  Talal  
N,  Weisman  MH,  and  the  European  Study  Group  on  Classification  Criteria  
for  Sjögren's  Syndrome.  Classification  criteria  for  Sjögren's  syndrome:  a  revised  
version  of  the  European  criteria  proposed  by  the  American-European  Consensus  




M.  Hirohata  et  al. 
Legends  for  figures 
   Figure  1.  Fluid  attenuated  inversion  recovery  MR  images  before  (A,  TR  
10,002  ms,  TE  175  ms)  and  5  weeks  after  the  initiation  of  corticosteroid  
therapy  (B,  TR  10,002  ms,  TE  157  ms).  High  signal  intensity  areas  were  
found  in  the  right  occipital  cortex  and  left  insular  cortex  involving  the  
subcortical  white  matter  (A).  After  five  weeks  of  therapy,  the  high  signal  
intensity  areas  were  no  longer  observed  (B).   
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